Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Hematology. American Society of Hematology. Education Program|December 9, 2023
Bispecific antibody therapiesLuiz Henrique de Assis, Daniel El Fassi, Martin HutchingsUgeskrift for Laeger|December 16, 2010
[The Pilgaard-Dahl syndrome: laughter-induced pneumothorax]Dorthe Bach Andreasen, Daniel El FassiUgeskrift for Laeger|June 21, 2008
[Novel treatment of Graves' disease using the B-lymphocyte depleting agent rituximab]Claus Henrik Nielsen, Daniel El Fassi, Laszlo HegedüsUgeskrift for Laeger|June 21, 2008
[Biological treatment options for Graves' ophthalmopathy]Daniel El Fassi, Claus Henrik Nielsen, Laszlo HegedüsUgeskrift for Laeger|December 1, 2006
[Rituximab (MabThera) as treatment of active rheumatoid arthritis]Daniel El Fassi, Claus Henrik Nielsen, Klaus BendtzenCancer Journal (Sudbury, Mass.)|September 25, 2018
Improvements in Imaging of Hodgkin Lymphoma: Positron Emission TomographyMartin HutchingsHematology/Oncology Clinics of North America|November 30, 2013
FDG-PET response-adapted therapy: is 18F-fluorodeoxyglucose positron emission tomography a safe predictor for a change of therapy?Martin HutchingsHematology. American Society of Hematology. Education Program|December 13, 2012
How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?Martin HutchingsPageof 16